Fujirebio expands its Alzheimer’s disease test menu

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio, have announced the availability of the Lumipulse^® G pTau 217 plasma assay for the fully automated LUMIPULSE G immunoassay systems.

This chemiluminescent enzyme immunoassay (CLEIA) assay allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human K2EDTA plasma within just 35 minutes.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>